Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid (Q44163469)

From Wikidata
Jump to navigation Jump to search
scientific article published in October 2002
edit
Language Label Description Also known as
English
Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid
scientific article published in October 2002

    Statements

    Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid (English)
    Nobuyuki Takayama
    Norihide Sato
    Stephen G O'Brien
    Yasuo Ikeda
    Shin-Ichiro Okamoto
    1 October 2002
    106-108

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit